Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Background Detection of M-type phospholipase A 2 receptor (PLA 2 R) can be used in
serologic diagnosis of idiopathic membranous nephropathy (IMN), but there are limited data …

Aim Serum levels of phospholipase A2 receptor antibody (PLA2R; SAb) and glomerular
deposits of PLA2R antigen (GAg) have been detected in patients with idiopathic …

Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful for affirming the diagnosis of
idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is …

Background The presence of antibodies against the M-type phospholipase A2 receptor
(PLA2R-AB) is considered to be a promising serological diagnostic biomarker of idiopathic …

Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of
Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China - PMC Back …

Autoantibody against phospholipase A2 receptor (anti-PLA2R) is a sensitive and specific
biomarker of idiopathic membranous nephropathy (iMN), being found in approximately 70 …

Background Anti–phospholipase A2 receptor (anti-PLA2R) is a promising biomarker for
diagnosis, activity evaluation, therapy monitoring, and prognostic estimation of primary …

Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …